ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 33 filers reported holding ETON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,152 | -12.2% | 350 | 0.0% | 0.00% | – |
| Q1 2024 | $1,312 | -14.4% | 350 | 0.0% | 0.00% | – |
| Q4 2023 | $1,533 | +5.0% | 350 | 0.0% | 0.00% | – |
| Q3 2023 | $1,460 | +19.5% | 350 | 0.0% | 0.00% | – |
| Q2 2023 | $1,222 | -9.3% | 350 | 0.0% | 0.00% | – |
| Q1 2023 | $1,348 | +36.6% | 350 | 0.0% | 0.00% | – |
| Q4 2022 | $987 | -99.9% | 350 | 0.0% | 0.00% | – |
| Q3 2022 | $735,000 | -19.8% | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $917,000 | -39.9% | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $1,526,000 | -49.8% | 350 | -50.6% | 0.00% | – |
| Q4 2021 | $3,037,000 | -21.2% | 708 | -7.5% | 0.00% | – |
| Q3 2021 | $3,856,000 | -61.7% | 765 | -53.2% | 0.00% | – |
| Q2 2021 | $10,059,000 | -36.4% | 1,633 | -24.4% | 0.00% | – |
| Q1 2021 | $15,804,000 | -34.0% | 2,159 | -26.7% | 0.00% | – |
| Q4 2020 | $23,959,000 | -3.7% | 2,947 | -6.4% | 0.00% | – |
| Q3 2020 | $24,869,000 | +726.8% | 3,148 | +470.3% | 0.00% | – |
| Q2 2020 | $3,008,000 | – | 552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,529,887 | $11,080,905 | 2.95% |
| Acuitas Investments, LLC | 492,054 | $2,155,197 | 1.12% |
| Westside Investment Management, Inc. | 563,110 | $2,466,424 | 0.63% |
| Parkman Healthcare Partners LLC | 199,168 | $872,356 | 0.12% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,314,000 | 0.07% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 78,613 | $344,325 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 253,362 | $1,109,726 | 0.02% |
| XTX Topco Ltd | 22,858 | $100,118 | 0.02% |
| Quantum Private Wealth, LLC | 11,500 | $50,370 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $73,146 | 0.02% |